GlassScriptPhysician profile
Ji Li
NPI 1558347310
$6,643.76
in general payments reported to CMS, 2019-2025
28 companies · $1,719 in 2025
The $1,719 reported for 2025 was more than what 79% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,669 · 2020: $443 · 2021: $267 · 2022: $822 · 2023: $675 · 2024: $1,048 · 2025: $1,719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,995 · Education: $303 · Travel and Lodging: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,994.85 |
| Education | $302.50 |
| Travel and Lodging | $144.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,926.74 | 2019-2025 | Proclaim, Eterna, Octrode |
| Medtronic, INC. | $464.64 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Osteocool Rf Ablation System |
| Abbvie INC. | $395.11 | 2022-2025 | |
| Boston Scientific Corporation | $76.49 | 2019-2024 | Intracept |
| Pfizer INC. | $74.99 | 2019-2025 | |
| Vertex Pharmaceuticals Incorporated | $69.07 | 2024-2025 | |
| Biodelivery Sciences International, INC. | $57.83 | 2020-2021 | |
| Radius Health, INC. | $50.69 | 2023 | Tymlos |
| Lundbeck LLC | $49.84 | 2023 | Vyepti |
| Si-Bone, INC. | $49.25 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $46.95 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.52 | 2022-2023 | Relistor |
| Zimmer Biomet Holdings, INC. | $36.56 | 2019 | |
| Neurocrine Biosciences, INC. | $33.48 | 2022-2025 | |
| Vertos Medical, INC. | $32.44 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $29.87 | 2019-2020 | |
| Stryker Corporation | $28.84 | 2025 | Mild Device Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $18.79 | 2022 | |
| Lilly USA, LLC | $18.50 | 2023 | Emgality |
| Globus Medical, INC. | $18.30 | 2025 | Senza |
| Painteq LLC | $17.71 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.85 | 2022 | |
| Nevro Corp. | $16.12 | 2021 | |
| Fidia Pharma USA INC. | $15.93 | 2021 | |
| Averitas Pharma INC. | $15.46 | 2024 | Qutenza |
| Amgen INC. | $13.57 | 2023 | Aimovig |
| Spr Therapeutics, INC | $13.32 | 2025 | Sprint Pns System |
| Foundation Fusion Solutions, LLC | $10.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ji Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.